Next Generation Anti-Tuberculosis Drugs

The research group Next-Gen-BTZ is integrated into the structural unit Transfer Group Antiinfectives.

The group focuses on the rational design of new generations of antibiotic ingredients against Mycobacterium tuberculosis, the causative pathogen of tuberculosis. In addition, yet unknown metabolic pathways are studied on a molecular level in order to understand and predict the efficacy and interactions of antituberculosis drug candidates currently being in clinical development.

The research group Next-Gen-BTZ is funded by the Free State of Thuringia with means of the European Social Fund.

Staff

Florian Kloß

Dr. Florian Kloß

Head

Phone: +49 3641 532-1356 Email: florian.kloss@leibniz-hki.de

Melanie Joch

Melanie Joch

Phone: +49 3641 532-1297 Email: melanie.joch@leibniz-hki.de

Francois Keiff

Francois Keiff

Phone: +49 3641 532-1096 Email: francois.keiff@leibniz-hki.de

Sebastian Schieferdecker

Dr. Sebastian Schieferdecker

Phone: +49 3641 532-1350 Email: sebastian.schieferdecker@leibniz-hki.de